These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2015-001918-98 RATe control in Atrial Fibrillation II 2021-11-12 due-trials
Ongoing 2018-001863-21 First-line treatment with osimertinib in EGFR-mutated non-small cell lung cancer, coupled to extensive translational studies not-yet-due
Completed, but no date 2018-004261-14 MUscle Side-Effects of atorvastatin in coronary patients (MUSE) bad-data
Ongoing 2019-003959-11 MUscle Side-Effects of atorvastatin in coronary patients (MUSE) follow-up study not-yet-due
Ongoing 2020-004920-40 Affective effects of pre-surgery opioids (AFFECT): a randomized double-blind controlled trial not-yet-due
Other 2021-001696-16 Sotorasib in advanced KRASG12C-mutated non-small cell lung cancer patients with comorbidities not-yet-due
Other 2021-005729-25 A Randomized Phase II, Open-label, Multicenter Study Investigating Efficacy and Safety of anti-PD-1/PD-L1 treatment +/- UV1 vaccination as first line treatment in patients with inoperable advanced or ... not-yet-due